Effect of mitoguazone on polyamine oxidase activity in rat liver.
Ferioli ME, Berselli D, Caimi S.
Toxicol Appl Pharmacol · journal article · DOI 10.1016/j.taap.2004.05.013 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för mitoguazone. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
24 träffarRapid and sensitive quantitation of the antiproliferative agent mitoguazone in small volumes of plasma by high-performance liquid chromatography with ultraviolet detection.
Cheng CL, Lin EG, Chou CH.
J Chromatogr B Analyt Technol Biomed Life Sci · research support, non-u.s. gov't; journal article · DOI 10.1016/s1570-0232(03)00328-3A phase I human trial of mitoguazone and gemcitabine sequential bi-weekly treatment of cancer patients.
Ishmael DR, Chen WR, Hamilton SA, Liu H, Nordquist RE.
Cancer Invest · clinical trial; research support, non-u.s. gov't; clinical trial, phase i; journal article · DOI 10.1081/cnv-120022370Evaluation of mitoguazone in patients with refractory chronic lymphocytic leukemia: a phase II study (P-H482) of the Eastern Cooperative Oncology Group.
Wiernik PH, Gordon LI, Oken MM, Harris JE, O'Connell MJ.
Leuk Lymphoma · clinical trial, phase ii; clinical trial; journal article · DOI 10.3109/10428199909145742Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481).
Wiernik PH, Moore DF, Bennett JM, Vogl SE, Harris JE, Luger S, Oken MM, Glick JH.
Leuk Lymphoma · clinical trial, phase ii; clinical trial; research support, u.s. gov't, p.h.s.; journal article · DOI 10.3109/10428199809057572Mitoguazone induces apoptosis via a p53-independent mechanism.
Davidson K, Petit T, Izbicka E, Koester S, Von Hoff DD.
Anticancer Drugs · research support, non-u.s. gov't; journal article · DOI 10.1097/00001813-199808000-00009The use of capillary electrophoresis as part of a specificity testing strategy for mitoguazone dihydrochloride HPLC methods.
Thomson CE, Gray MR, Baxter MP.
J Pharm Biomed Anal · comparative study; journal article · DOI 10.1016/s0731-7085(96)02001-8Pharmacokinetic profile of Mitoguazone (MGBG) in patients with AIDS related non-Hodgkin's lymphoma.
Rizzo J, Levine AM, Weiss GR, Pearce T, Kraynak M, Mueck R, Smith S, Von Hoff DD, Kuhn JG.
Invest New Drugs · clinical trial, phase ii; clinical trial; research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1007/bf00210796Influence of leukemia P388 on the pharmacokinetics of mitoguazone in B6D2F1 mice.
Amlacher R, Sühnel J, Baumgart J, Mackowiak A, Schulze W, Bubner M, Hoffmann H.
Pharmazie · journal articlePhase II trial of methyl-gag and melphalan in metastatic adult renal cell carcinoma.
Guimaraes JL, Ghosn M, Ostronoff M, Azab M, Theodore C, Droz JP.
Cancer Invest · clinical trial; journal article · DOI 10.3109/07357909009018930[Mitoguazone (methylglyoxal bis(guanylhydrazone))--its status and prospects].
Hoffmann H, Gutsche W, Amlacher R, Schulze W, Werner W, Lenk H, Wohlrab W, Haupt E.
Arch Geschwulstforsch · clinical trial; review; journal article; english abstractLiposomes as carrier of methyl-GAG. Increased antitumor activity and reduced hypoglycemia in mice.
Arndt D, Fichtner I, Nissen E.
Oncology · comparative study; journal article · DOI 10.1159/000226490Phase II trial of methylglyoxal-bis-guanylhydrazone (methyl-GAG) in patients with soft-tissue sarcomas.
Sordillo PP, Magill GB, Welt S.
Am J Clin Oncol · clinical trial; research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1097/00000421-198508000-00008Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in advanced breast cancer. A Phase II trial of the Southwest Oncology Group.
Knight WA, O'Bryan RM, Samal B, Costanzi JJ.
Invest New Drugs · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1007/bf00173789Dialyzability of methyl-GAG.
Jensen B, Williams RD, Ohnuma T, Roboz J.
Cancer Treat Rep · journal article; case reportsPhase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck.
Perry DJ, Crain SM, Weltz MD, Wilson JP, Davis RK, Woolley PV, Forastiere AA, Taylor HG, Weiss RB.
Cancer Treat Rep · journal articleMethyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in lymphoma and Hodgkin's disease. A Phase II trial of the Southwest Oncology Group.
Knight WA, Fabian C, Costanzi JJ, Jones SE, Coltman CA.
Invest New Drugs · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1007/bf00208895The effects of Methyl-GAG on a transplantable murine renal cell adenocarcinoma.
Williams PD, Murphy GP.
Res Commun Chem Pathol Pharmacol · research support, non-u.s. gov't; journal articlePhase II study of methyl-GAG in the treatment of esophageal carcinoma.
Kelsen D, Chapman R, Bains M, Heelan R, Dukeman M, Golbey R.
Cancer Treat Rep · research support, u.s. gov't, p.h.s.; journal articleCombination chemotherapy for patients with relapsed malignant lymphoma using methyl-GAG and teniposide (VM-26).
Warrell RP, Straus DJ, Young CW.
Cancer Treat Rep · clinical trial; research support, u.s. gov't, p.h.s.; journal articlePhase II evaluation of methyl-GAG in patients with refractory metastatic breast cancer.
Yap HY, Blumenschein GR, Schell F, Bodey GP.
Cancer Treat Rep · research support, u.s. gov't, p.h.s.; journal articlePlasma levels and urinary excretion of methyl-GAG following iv infusion in man.
Marsh KC, Liesmann J, Patton TF, Fabian CJ, Sternson LA.
Cancer Treat Rep · research support, u.s. gov't, p.h.s.; journal articleMethyl glyoxal bis guanylhydrazone abolition of the toxic action of spermidine on cells in culture.
Dewey DL.
Cancer Lett · journal article · DOI 10.1016/s0304-3835(79)80041-5[Histochemical and ultrastructural investigations on the activity of methylglyoxal (bis)-guanylhydrozan (methyl-GAG) on organ cultures of malignant tumors (author's transl)].
Hecker D, Rose H.
Arch Geschwulstforsch · journal article; english abstract